[Elsevier] Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan

camilo0595 Post time 2026-10-17 22:14:05 | Show all posts |Read mode
This post will be closed automatically in 2026-10-20 22:13
Reward10points

revista: Oncolog赤a radioter芍pica cl赤nica y traslacional

Autores: Yoshiko Oshiro; Masashi Mizumoto; Yuta Sekino; Kazushi Maruo; Toshiki Ishida; Taisuke Sumiya; Masatoshi Nakamura; Ayako Ohkawa; Daichi Takizawa; Toshiyuki Okumura; Yoshio Tamaki; Hideyuki Sakurai

Fecha de publicaci車n: 2021-7-

DOI: 10.1016/j.ctro.2021.05.009

Enlace PDF: https://www.sciencedirect.com/sc ... 405630821000537/pdf

Enlace del art赤culo: https://doi.org/10.1016/j.ctro.2021.05.009

Fuente del art赤culo: Elsevier BV .


Nota:

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply2 Show all posts
asfrgr21236 Post time 2026-10-17 22:14:06 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

camilo0595 Post time 2026-10-18 03:28:00 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    50


Daily Top Contributors

Return to the list